Clinical Trial Update: RHPRG4 FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of RHPRG4 for Sjögren's syndrome–associated dry eye was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome with Dry Eye

Drugs mentioned

• RHPRG4

Snippet

Sponsor: Lubris Bio Pty Ltd | Conditions: Sjogren's Syndrome With Dry Eye | Phase 1, Phase 2 | Status: TERMINATED